Michael Alpers | Academic Influence

Michael Alpers's AcademicInfluence.com Rankings

Michael Alpers

Law

#1943

World Rank

#2423

Historical Rank

Common Law

#88

World Rank

#96

Historical Rank

Download Badge

Law

Michael Alpers's Degrees

Bachelors Biology University of California, Berkeley
Doctorate Medicine Stanford University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is Michael Alpers Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Michael Philip Alpers , , is an Australian medical researcher, and John Curtin distinguished Professor of International Health, at Curtin University. Education Alpers graduated from University of Adelaide with a B.Sc. and M.B.B.S. and from University of Cambridge with an M.A.

(See a Problem?)

Michael Alpers's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Experimental Transmission of a Kuru-like Syndrome to Chimpanzees (1966) (814)
Creutzfeldt-Jakob Disease (Spongiform Encephalopathy): Transmission to the Chimpanzee (1968) (735)
A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. (2002) (503)
Research and Development (1997) (489)
Plasmodium vivax and Mixed Infections Are Associated with Severe Malaria in Children: A Prospective Cohort Study from Papua New Guinea (2008) (469)
Balancing Selection at the Prion Protein Gene Consistent with Prehistoric Kurulike Epidemics (2003) (390)
High frequencies of α-thalassaemia are the result of natural selection by malaria (1986) (327)
i Published online by: (2001) (319)
alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. (1997) (307)
Kuru in the 21st century—an acquired human prion disease with very long incubation periods (2006) (306)
Creutzfeldt-Jakob disease. The neuropathology of a transmission experiment. (1969) (273)
Blood Pressure in Four Remote Populations in the INTERSALT Study (1989) (249)
Effect of vitamin A supplementation on morbidity due to Plasmodium falciparum in young children in Papua New Guinea: a randomised trial (1999) (247)
The epidemiology of malaria in a population surrounding Madang, Papua New Guinea. (1986) (233)
Cross-species interactions between malaria parasites in humans. (2000) (231)
Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea. (1999) (206)
Ovalocytosis and cerebral malaria (1995) (180)
The epidemiology of malaria in Papua New Guinea. (2003) (180)
The association between Dermatophagoides mites and the increasing prevalence of asthma in village communities within the Papua New Guinea highlands. (1985) (179)
Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. The WHO Young Infants Study Group. (1999) (177)
Prevention of cerebral malaria in children in Papua New Guinea by southeast Asian ovalocytosis band 3. (1999) (169)
Transmission and passage of experimenal "kuru" to chimpanzees. (1967) (169)
The influence of zinc supplementation on morbidity due to Plasmodium falciparum: a randomized trial in preschool children in Papua New Guinea. (2000) (168)
PNEUMOCOCCAL VACCINE PREVENTS DEATH FROM ACUTE LOWER-RESPIRATORY-TRACT INFECTIONS IN PAPUA NEW GUINEAN CHILDREN (1986) (160)
The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. I. Malariometric indices and immunity. (1995) (158)
A novel protective prion protein variant that colocalizes with kuru exposure. (2009) (154)
A naturally occurring variant of the human prion protein completely prevents prion disease (2015) (151)
Measurement of malarial infectivity of human populations to mosquitoes in the Madang area, Papua New Guinea (1988) (150)
Plasmodium falciparum: extensive polymorphism in merozoite surface antigen 2 alleles in an area with endemic malaria in Papua New Guinea. (1994) (147)
Increased susceptibility to Kuru of carriers of the PRNP 129 methionine/methionine genotype. (2001) (144)
Genetic diversity and dynamics of Plasmodium falciparum and P. vivax populations in multiply infected children with asymptomatic malaria infections in Papua New Guinea (2000) (143)
Reduced risk of clinical malaria in children infected with multiple clones of Plasmodium falciparum in a highly endemic area: a prospective community study. (1997) (142)
Genetic risk factors for variant Creutzfeldt–Jakob disease: a genome-wide association study (2009) (141)
Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children (1993) (141)
Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children. (2003) (131)
Random distribution of mixed species malaria infections in Papua New Guinea. (2000) (129)
High frequencies of alpha-thalassaemia are the result of natural selection by malaria. (1986) (128)
Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity. (1996) (128)
Associations of peak shifts in age--prevalence for human malarias with bednet coverage. (2001) (123)
Mass treatment to eliminate filariasis in Papua New Guinea. (2002) (122)
Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes (1998) (117)
Human cerebral malaria: lack of significant association between erythrocyte rosetting and disease severity. (1995) (117)
Relation of anthropometry to malaria morbidity and immunity in Papua New Guinean children. (1998) (115)
Natural variation within the principal adhesion domain of the Plasmodium vivax duffy binding protein (1994) (106)
A comparison of epstein‐barr virus‐specific T‐cell immunity in malaria‐endemic and ‐nonendemic regions of Papua New Guinea (1983) (104)
The Natural Incubation Period of Kuru and the Episodes of Transmission in Three Clusters of Patients (1984) (103)
Bacterial Colonization of tbe Upper Respiratory Tract and Its Association witb Acute Lower Respiratory Tract Infections in Higbland Cbildren of Papua New Guinea (1990) (102)
Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea. (1994) (101)
Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea. (2000) (100)
Plasmodium falciparum: malaria morbidity is associated with specific merozoite surface antigen 2 genotypes. (1995) (96)
Area effects of bednet use in a malaria-endemic area in Papua New Guinea. (2001) (95)
Pneumonia in children in the Eastern Highlands of Papua New Guinea: a bacteriologic study of patients selected by standard clinical criteria. (1989) (94)
Identification of Plasmodium vivax-like human malaria parasite (1993) (93)
Age- and species-specific duration of infection in asymptomatic malaria infections in Papua New Guinea (2000) (91)
Malaria: how useful are clinical criteria for improving the diagnosis in a highly endemic area? (1994) (90)
Transmission intensity and its relationship to infection and disease due to Wuchereria bancrofti in Papua New Guinea. (1997) (89)
The prevalence of Serpulina pilosicoli in humans and domestic animals in the Eastern Highlands of Papua New Guinea (1997) (89)
The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. II. Mortality and morbidity. (1995) (87)
Hereditary ovalocytosis and reduced susceptibility to malaria in Papua New Guinea. (1987) (85)
Benefits of routine immunizations on childhood survival in Tari, Southern Highlands Province, Papua New Guinea. (2004) (84)
Transmission of scrapie in hamsters. (1985) (83)
Dynamics of malaria parasitaemia associated with febrile illness in children from a rural area of Madang, Papua New Guinea. (1994) (82)
Reduction in incidence and prevalence of Plasmodium falciparum in under-5-year-old children by permethrin impregnation of mosquito nets. (1987) (82)
Relationships between Plasmodium falciparum infection and morbidity in a highly endemic area (1994) (81)
A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea (2008) (81)
Plasmodium falciparum-specific immunoglobulin G (IgG), IgM, and IgE antibodies in paired maternal-cord sera from east Sepik Province, Papua New Guinea (1993) (80)
Occurrence of the erythrocyte band 3 (AE1) gene deletion in relation to malaria endemicity in Papua New Guinea. (1996) (79)
Association between serum levels of reactive nitrogen intermediates and coma in children with cerebral malaria in Papua New Guinea. (1996) (79)
Comparison of single-dose diethylcarbamazine and ivermectin for treatment of bancroftian filariasis in Papua New Guinea. (1993) (78)
Increased Microerythrocyte Count in Homozygous α+-Thalassaemia Contributes to Protection against Severe Malarial Anaemia (2008) (74)
Prospective risk of morbidity in relation to malaria infection in an area of high endemicity of multiple species of Plasmodium. (2001) (73)
Strain-Specific Humoral Response to a Polymorphic Malaria Vaccine (2004) (73)
Age specific patterns of change in the dynamics of Wuchereria bancrofti infection in Papua New Guinea. (1991) (73)
Diversity of agglutinating phenotype, cytoadherence, and rosette-forming characteristics of Plasmodium falciparum isolates from Papua New Guinean children. (1994) (72)
The epidemiology of kuru: monitoring the epidemic from its peak to its end (2008) (72)
HECTD2 Is Associated with Susceptibility to Mouse and Human Prion Disease (2009) (72)
Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP. (2012) (71)
Comparison between anopheline mosquitoes (Diptera: Culicidae) caught using different methods in a malaria endemic area of Papua New Guinea (2000) (71)
Treatment with ivermectin reduces the high prevalence of scabies in a village in Papua New Guinea. (2000) (70)
Clinical prediction of serious bacterial infections in young infants in developing countries. The WHO Young Infants Study Group. (1999) (69)
T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic (1997) (68)
Changing patterns of kuru: epidemiological changes in the period of increasing contact of the Fore people with western civilization. (1965) (67)
Plasmodium vivax: favored gene frequencies of the merozoite surface protein-1 and the multiplicity of infection in a malaria endemic region. (1996) (67)
Experimental "kuru" in chimpanzees. A pathological report. (1966) (66)
Community based study of sexually transmitted diseases in rural women in the highlands of Papua New Guinea: prevalence and risk factors. (1998) (65)
The late biting habit of parous Anopheles mosquitoes and pre-bedtime exposure of humans to infective female mosquitoes. (1996) (64)
Failure of chloroquine prophylaxis for falciparum malaria in pregnant women in Madang, Papua New Guinea. (1990) (64)
Mass treatment with ivermectin for filariasis control in Papua New Guinea: impact on mosquito survival (1999) (64)
The ecology of the Anopheles punctulatus group of mosquitoes from Papua New Guinea: a review of recent work. (1986) (64)
Transmission dynamics of Wuchereria bancrofti in East Sepik Province, Papua New Guinea. (1996) (63)
Relationship between mite densities and the prevalence of asthma: comparative studies in two populations in the Eastern Highlands of Papua New Guinea (1988) (62)
Spatial and temporal variation in abundance of Anopheles (Diptera:Culicidae) in a malaria endemic area in Papua New Guinea. (1997) (62)
Characterization of a variant of human T-lymphotropic virus type I isolated from a healthy member of a remote, recently contacted group in Papua New Guinea. (1991) (61)
A seroepidemiological study to evaluate the role of passive maternal immunity to malaria in infants. (1989) (61)
Human Immunodeficiency Virus and Other Sexually Transmitted Infections Among Female Sex Workers in Two Major Cities in Papua New Guinea (2002) (60)
Kuru with incubation periods exceeding two decades (1982) (59)
Man-made lakes and human health. (1975) (58)
Disposition of Artesunate and Dihydroartemisinin after Administration of Artesunate Suppositories in Children from Papua New Guinea with Uncomplicated Malaria (2004) (57)
Humoral and cell-mediated immunity to the Plasmodium falciparum ring-infected erythrocyte surface antigen in an adult population exposed to highly endemic malaria (1995) (54)
Polymerase chain reaction diagnosis and the changing pattern of vector ecology and malaria transmission dynamics in papua new Guinea. (2004) (54)
Human biology in Papua New Guinea: the small cosmos. (1994) (54)
Modernity and obesity in coastal and Highland Papua New Guinea. (1995) (52)
The prevalence of asthma in the South-Fore people of Papua New Guinea. A method for field studies of bronchial reactivity. (1983) (50)
Application of a polymerase chain reaction-ELISA to detect Wuchereria bancrofti in pools of wild-caught Anopheles punctulatus in a filariasis control area in Papua New Guinea. (2000) (50)
Clinical signs and risk factors associated with pneumonia in children admitted to Goroka Hospital, Papua New Guinea. (1989) (49)
The use of untreated bednets and malaria infection, morbidity and immunity. (1994) (49)
Sulfadoxine-pyrimethamine for the treatment of acute malaria in children in Papua New Guinea. I. Plasmodium falciparum. (1982) (49)
Indicators of fatal outcome in paediatric cerebral malaria: a study of 134 comatose Papua New Guinean children. (1997) (49)
Placental Plasmodium falciparum parasitaemia in East Sepik (Papua New Guinea) women of different parity: the apparent absence of acute effects on mother and foetus. (1992) (49)
Bacterial and viral etiology of severe infection in children less than three months old in the highlands of Papua New Guinea. (1999) (48)
Relationships between growth and acute lower-respiratory infections in children aged less than 5 y in a highland population of Papua New Guinea. (1991) (48)
Transmission Intensity Determines Lymphocyte Responsiveness and Cytokine Bias in Human Lymphatic Filariasis1 (2001) (48)
Wide distribution of the variant form of the human malaria parasite Plasmodium vivax. (1991) (48)
Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation. (2008) (47)
Small-area variations in the epidemiology of malaria in Madang Province. (1986) (47)
Maternal immunization with pneumococcal polysaccharide vaccine in the highlands of Papua New Guinea. (2002) (47)
Small area variation in prevalence of an S-antigen serotype of Plasmodium falciparum in villages of Madang, Papua New Guinea. (1989) (47)
Plasmodium falciparum strains from Papua New Guinea: culture characteristics and drug sensitivity. (1980) (46)
Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease (2008) (46)
Studies of maternal immunisation with pneumococcal polysaccharide vaccine in Papua New Guinea. (2003) (46)
Ecologic and biologic determinants of filarial antigenemia in bancroftian filariasis in Papua New Guinea. (2001) (45)
Studies on bronchial hyperreactivity, allergic responsiveness, and asthma in rural and urban children of the highlands of Papua New Guinea. (1986) (44)
Diversity in the immunodominant determinants of the circumsporozoite protein of Plasmodium falciparum parasites from malaria-endemic regions of Papua New Guinea and Brazil. (1992) (44)
Global occurrence of Plasmodium vivax-like human malaria parasite. (1993) (43)
Genetic studies in relation of kuru. I. Cultural, historical, and demographic background. (1972) (43)
12 Infectious and Sporadic Prion Diseases (1999) (43)
Genetic susceptibility, evolution and the kuru epidemic (2008) (43)
Immunoglobulin G antibody responses to polyvalent pneumococcal vaccine in children in the highlands of Papua New Guinea (1994) (42)
Identification of T epitopes within a potential Plasmodium falciparum vaccine antigen. A study of human lymphocyte responses to repeat and nonrepeat regions of Pf155/RESA. (1988) (42)
A Neolithic expansion, but strong genetic structure, in the independent history of New Guinea (2017) (42)
Aetiology and clinical signs of bacterial meningitis in children admitted to Goroka Base Hospital, Papua New Guinea, 1989-1992. (1999) (42)
Safety and Immunogenicity of Neonatal Pneumococcal Conjugate Vaccination in Papua New Guinean Children: A Randomised Controlled Trial (2013) (42)
The Malaria Vaccine Epidemiology and Evaluation Project of Papua New Guinea: rationale and baseline studies. (1992) (41)
Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequences (1996) (41)
The Incubation Period of Kuru (2002) (41)
Heritability and segregation analysis of immune responses to specific malaria antigens in Papua New Guinea (1999) (41)
Effect of the malaria vaccine Combination B on merozoite surface antigen 2 diversity. (2007) (39)
Pneumococcal vaccine trials in Papua New Guinea: relationships between epidemiology of pneumococcal infection and efficacy of vaccine. (1991) (39)
Polymorphism in the circumsporozoite protein of the human malaria parasite Plasmodium vivax. (1992) (38)
Resistance of Plasmodium falciparum malaria to amodiaquine, chloroquine and quinine in the Madang Province of Papua New Guinea, 1990-1993. (1996) (38)
Genetic inheritance of susceptibility to tinea imbricata. (1980) (37)
A continuing high incidence of subacute sclerosing panencephalitis (SSPE) in the Eastern Highlands of Papua New Guinea (2003) (37)
Evidence of HLA class II association with antibody response against the malaria vaccine SPF66 in a naturally exposed population. (1995) (36)
Smoke as a form of personal protection against mosquitos, a field study in Papua New Guinea. (1994) (35)
Field evaluation of the use of an ELISA to detect chloroquine and its metabolites in blood, urine and breast-milk. (1990) (35)
Urbanization, youth and sexuality: insights for an AIDS campaign for youth in Papua New Guinea. (1996) (35)
PRECLINICAL LESIONS AND THEIR PROGRESSION IN THE EXPERIMENTAL SPONGIFORM ENCEPHALOPATHIES (KURU AND CREUTZFELDT‐JAKOB DISEASE) IN PRIMATES (1976) (35)
Three different Plasmodium species show similar patterns of clinical tolerance of malaria infection (2009) (35)
Effect of pneumococcal vaccine on morbidity from acute lower respiratory tract infections in Papua New Guinean children. (1991) (35)
Glucose tolerance in a highland population in Papua New Guinea. (1984) (33)
Kuru and Creutzfeldt-Jakob disease: clinical and aetiological aspects. (1971) (33)
Mortuary rites of the South Fore and kuru (2008) (33)
Human polyomavirus JC variants in Papua New Guinea and Guam reflect ancient population settlement and viral evolution. (2000) (33)
Treatment-seeking behaviour among the Nasioi people of Bougainville: choosing between traditional and western medicine (2009) (33)
Serum lipids and modernization in coastal and highland Papua New Guinea. (1996) (32)
The acute phase response in children with mild and severe malaria in Papua New Guinea. (2009) (32)
Diagnosis of Plasmodium falciparum infection using ParaSight(R)-F test in blood and urine of Papua New Guinean children. (1998) (32)
Humoral response to Plasmodium falciparum ring-infected erythrocyte surface antigen in a highly endemic area of Papua New Guinea. (1995) (31)
Conclusions from the WHO multicenter study of serious infections in young infants. The WHO Young Infants Study Group. (1999) (31)
Natural antibody responses against the non-repeat-sequence-based B-cell epitopes of the Plasmodium falciparum circumsporozoite protein (1993) (30)
Assessment of different sources of variation in the antibody responses to specific malaria antigens in children in Papua New Guinea. (2000) (30)
Antifilarial IgG4 antibodies in children from filaria-endemic areas correlate with duration of infection and are dissociated from antifilarial IgE antibodies. (1994) (29)
Immunoprecipitation of biosynthetically‐labelled proteins from different Papua New Guinea Plasmodium falciparum isolates by sera from individuals in the endemic area (1981) (29)
TRANSMISSION EXPERIMENTS WITH KURU IN CHIMPANZEES AND THE ISOLATION OF LATENT VIRUSES FROM THE EXPLANTED TISSUES OF AFFECTED ANIMALS (1969) (28)
Ord River arboviruses--isolations from mosquitoes. (1976) (28)
Screening for sexually transmitted diseases in rural women in Papua New Guinea: are WHO therapeutic algorithms appropriate for case detection? (1998) (28)
Humoral response to defined Plasmodium falciparum antigens in cerebral and uncomplicated malaria and their relationship to parasite genotype. (1997) (28)
Cell-mediated immunity to Epstein–Barr virus and a blocking factor in patients with infectious mononucleosis (1974) (28)
Absence of ivermectin-associated excess deaths. (1998) (27)
Immunologic cross-reactivity between structural proteins of human T-cell lymphotropic virus type I and the blood stage of Plasmodium falciparum (1994) (27)
Safety and therapeutic efficacy of artesunate suppositories for treatment of malaria in children in Papua New Guinea (2003) (27)
A longitudinal study of splenomegaly in pregnancy in a malaria endemic area in Papua New Guinea. (1988) (27)
Single amino acid variation in the ookinete vaccine antigen from field isolates of Plasmodium falciparum. (1992) (26)
Bacterial, viral and parasitic aetiology of paediatric diarrhoea in the highlands of Papua New Guinea. (2000) (26)
The relationship between the in vitro response of Plasmodium falciparum to chloroquine, quinine and mefloquine. (1984) (25)
Differential antibody responses to Plasmodium falciparum and P. vivax circumsporozoite proteins in a human population (1989) (25)
Blood lead levels in Papua New Guinea children living in remote area. (1980) (25)
Association between cellular response (IL‐4) to RESA/Pf155 and protection from clinical malaria among Papua New Guinean children living in a malaria endemic area (1997) (25)
Efficacy of single-dose diethylcarbamazine compared with diethylcarbamazine combined with albendazole against Wuchereria bancrofti infection in Papua New Guinea. (2007) (25)
Antenatal care in Goroka: issues and perceptions. (2004) (25)
Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea. (2005) (24)
New approaches to the serotypic analysis of the epidemiology of Plasmodium falciparum. (1988) (24)
Mortality in a rural area of Madang Province, Papua New Guinea. (1989) (24)
Neuropathological comparisons of experimental kuru in chimpanzees with human kuru. (1969) (24)
High rates of Chlamydia trachomatis infections in young Papua New Guinean infants. (1999) (24)
A clinico-pathological study of a case of kuru (1983) (24)
Sequence variations in the non-repetitive regions of the liver stage-specific antigen-1 (LSA-1) of Plasmodium falciparum from field isolates. (1995) (24)
Genetic studies in relation to kuru. 3. Distribution of the inherited serum group-specific protein (Ge) phenotypes in New Guineans: an association of kuru and the Gc Ab phenotype. (1972) (24)
Serious infections in young infants in developing countries: rationale for a multicenter study. The WHO Young Infants Study Group. (1999) (23)
Cellular immunity to merozoite surface protein 2 (FC27 and 3D7) in Papua New Guinean children. Temporal variation and relation to clinical and parasitological status (1997) (23)
The population dynamics in mosquitoes and humans of two Plasmodium vivax polymorphs distinguished by different circumsporozoite protein repeat regions. (1992) (23)
Viruses associated with acute lower respiratory tract infections in children from the eastern highlands of Papua New Guinea (1983-1985). (1990) (23)
Patterns of migration indicate sexual transmission of HTLV‐I infection in non‐pregnant women in papua new guinea (1989) (23)
Serological evaluation of the macrofilaricidal effects of diethylcarbamazine treatment in bancroftian filariasis. (1991) (22)
13 Infectious and Sporadic Prion Diseases (2004) (22)
Genetic analysis of IgG subclass responses against RESA and MSP2 of Plasmodium falciparum in adults in Papua New Guinea (2000) (22)
Epidemiological studies of Epstein–Barr herpesvirus infection in Western Australia (1975) (22)
Genetic studies in relation to kuru. II. Blood-group genetic patterns in kuru patients and populations of the Eastern Highlands of New Guinea. (1972) (22)
Parental infection confounded with local infection intensity as risk factors for childhood microfilaraemia in bancroftian filariasis. (1998) (21)
Utilization of urea nitrogen in Papua New Guinea highlanders. (1985) (21)
Mortality rates and the utilization of health services during terminal illness in the Asaro Valley, Eastern Highlands Province, Papua New Guinea. (1999) (20)
The use of the polymerase chain reaction for more sensitive detection of Plasmodium falciparum. (1995) (20)
The malaria vaccine development program in Papua New Guinea. (2003) (20)
Ineffectiveness of amodiaquine against Plasmodium falciparum malaria in symptomatic young children living in an endemic malarious area of Papua New Guinea. (1991) (20)
The relationship between undernutrition and humoral immune status in children with pneumonia in Papua New Guinea. (2008) (20)
Salivary and serum antibody responses to Haemophilus influenzae infection in Papua New Guinea. (1987) (20)
Hydrocephalus in Mice Inoculated Neonatally by the Oronasal Route with Reovirus Type 1 (1970) (20)
Attempts to transmit subacute and chronic neurological diseases to animals. (1969) (19)
Acute disease episodes in a Wuchereria bancrofti-endemic area of Papua New Guinea. (1999) (19)
Ord River arboviruses--serological epidemiology. (1976) (19)
Evidence that recurrent Plasmodium falciparum infection is caused by recrudescence of resistant parasites. (1997) (19)
Detection of Streptococcus pneumoniae and Haemophilus influenzae type b antigens in the serum and urine of patients with pneumonia in Papua New Guinea: comparison of latex agglutination and counterimmunoelectrophoresis. (1990) (19)
Leukocyte antigens in a New Guinea population. (2008) (19)
Spatial variation of Anopheles-transmitted Wuchereria bancrofti and Plasmodium falciparum infection densities in Papua New Guinea (2003) (19)
Prevalence of asthma in the South Fore people of the Okapa District of Papua New Guinea. Features associated with a recent dramatic increase. (1985) (18)
Synthesis of virus-capsid antigen (VCA) enhanced by ultraviolet irradiation of a lymphoblastoid cell line carrying Epstein-Barr virus. (1973) (17)
Sulfadoxine-pyrimethamine for the treatment of acute malaria in children of Papua New Guinea. II. Plasmodium vivax. (1982) (17)
Relative repellency of woodsmoke and topical applications of plant products against mosquitoes. (1995) (17)
Isolation of HTLV-I from members of a remote tribe in New Guinea. (1990) (17)
Genetic studies in relation to kuru. V. Distribution of human gamma globulin allotypes in New Guinea populations. (1972) (17)
Acquired antibody levels to Plasmodium falciparum merozoite surface antigen 1 in residents of a highly endemic area of Papua New Guinea. (1995) (17)
Experimental Kuru in the Gibbon and Sooty Mangabey and Creutzfeldt‐Jakob Disease in the Pigtailed Macaque (1976) (17)
Reduction in Acute Filariasis Morbidity during a Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea (2011) (16)
Plasma glucose and insulin responses in young Papua New Guineans (aged 10-19 years). (1990) (16)
Asthma in a rural highland area of Papua New Guinea. (1981) (16)
Disruption of erythrocyte rosettes and agglutination of erythrocytes infected with Plasmodium falciparum by the sera of Papua New Guineans. (1996) (16)
Amyloidosis: a global problem common in Papua New Guinea. (1996) (15)
Subacute sclerosing panencephalitis (SSPE) in Papua New Guinea: a high incidence in young children (1992) (15)
Newborn splenic volumes vary under different malaria endemic conditions. (1989) (15)
Ord River arboviruses--the study site and mosquitoes. (1976) (15)
The role of voluntary village aides in the control of malaria by presumptive treatment of fever. 2. Impact on village health. (1985) (15)
Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua New Guinean children from four months of age. (1991) (15)
Assessment of the humoral and cell-mediated immunity against the Plasmodium falciparum vaccine candidates circumsporozoite protein and SPf66 in adults living in highly endemic malarious areas of Papua New Guinea. (1994) (14)
The epidemiology of kuru in the period 1987 to 1995. (2005) (14)
Towards eliminating lymphatic filariasis in Papua New Guinea: impact of annual single-dose mass treatment on transmission of Wuchereria bancrofti in East Sepik Province. (2000) (14)
Blood pressure in Papua New Guinea: a survey of two highland villages in the Asaro Valley. (1985) (14)
Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea. (1992) (14)
Resistance of Plasmodium falciparum to amodiaquine in Papua New Guinea. (1993) (14)
Blood pressure, hypertension and other cardiovascular risk factors in six communities in Papua New Guinea, 1985-1986. (1994) (14)
Higher risk of post‐partum hemorrhage in malarious than in non‐malarious areas of Papua New Guinea (2001) (14)
Emergence of FY * Anull in a Plasmodium vivax-endemic region of Papua New Guinea (1999) (13)
Iron and infection in infancy--report on field studies in Papua New Guinea: II. Protocol and description of study cohort. (1984) (13)
Antigenicity of a protective recombinant filarial protein in human bancroftian filariasis. (1992) (13)
Responses of sodium balance, blood pressure, and other variables to sodium loading in Papua New Guinea highlanders. (1988) (13)
Two populations of women with high and low spleen rates living in the same area of Madang, Papua New Guinea, demonstrate different immune responses to malaria. (1989) (13)
Resistance of Plasmodium falciparum in vivo to 3 days' treatment with quinine and single-dose Fansidar. (1994) (13)
Immunological assessment of mice with chronic jaundice and runting induced by reovirus 3. (1973) (12)
Altitude, language, and class I HLA allele frequencies in Papua New Guinea. (1994) (12)
Asthma and chronic airflow limitation in the highlands of Papua New Guinea: low prevalence of asthma in the Asaro Valley. (1989) (12)
Prenatal immune hypersensitization to malaria: Plasmodium falciparum-specific IgE antibody in paired maternal and cord sera from Papua New Guinea. (1992) (12)
Diet in an urban Papua New Guinea population with high levels of cardiovascular risk factors (1996) (12)
Development of cell-mediated immunity to Epstein-Barr herpesvirus in infectious mononucleosis as shown by leukocyte migration inhibition (1977) (12)
Isolation of Fusobacterium nucleatum and electron microscopic observations of spirochetes from tropical skin ulcers in Papua New Guinea. (1989) (11)
A novel JC virus variant found in the Highlands of Papua New Guinea has a 21-base pair deletion in the agnoprotein gene. (1999) (11)
The role of voluntary village aides in the control of malaria by presumptive treatment of fever. 1. Selection, training and practice. (1985) (11)
Migration and dispersal of lymphatic filariasis in Papua New Guinea. (2001) (11)
Chemoprophylaxis against malaria in Papua New Guinea: a trial of amodiaquine and a combination of dapsone and pyrimethamine. (1992) (11)
The epidemiology and control of lymphatic filariasis on Lihir Island, New Ireland Province. (2000) (10)
Pneumococcal antibody concentrations in young Papua New Guinean Highland children with pneumonia. (1989) (10)
Kuru in childhood: Disappearance of the disease in the younger age group (1966) (10)
Glucose Tolerance in Papua New Guinea: Comparison of Austronesian and Non‐Austronesian Communities of Karkar Island (1991) (10)
Delayed hypersensitivity in the marsupial Setonix brachyurus (quokka). (1972) (10)
Studies on malaria in Papua New Guinea: comparison of the surface glycoproteins on red blood cells from infected and uninfected individuals (1981) (10)
Bibliography of kuru (1970) (10)
Restricted polymorphisms of the mannose-binding lectin gene in a population of Papua New Guinea. (2002) (10)
Rifampicin/Cotrimoxazole/Isoniazid Versus Mefloquine or Quinine + Sulfadoxine- Pyrimethamine for Malaria: A Randomized Trial (2006) (10)
In vitro evaluation of cell-mediated immunity to Epstein-Barr herpesvirus by cell migration inhibition tests. (1975) (9)
Vaccines against malaria: Perspectives from Papua, New Guinea (2010) (9)
Investigation of the effect of monocytes with Papua New Guinea sera on Plasmodium falciparum in culture. (1988) (9)
The expression of Plasmodium falciparum bloodstage antigens in Escherichia coli. (1984) (8)
Mosquito nets for the elderly? (2002) (8)
Clinical presentation of subacute sclerosing panencephalitis in Papua New Guinea (2003) (8)
Endogenous nitrogen excretion in male highlanders of Papua New Guinea. (1984) (8)
Studies of nitrogen balance in male highlanders in Papua New Guinea. (1986) (8)
Smoking habits in a rural community in the Highlands of Papua New Guinea in 1970 and 1984. (1987) (8)
A history of kuru. (2007) (7)
A lymphoblastoid cell line derived from cells of myeloid leukemia by infection with the Epstein-Barr herpes virus. (1973) (7)
Some tributes to research colleagues and other contributors to our knowledge about kuru (2008) (7)
Levels of anti-pneumococcal antibodies in young children in Papua New Guinea (1993) (7)
Mitochondrial DNA Variation in the Southwest Pacific (1999) (7)
Control of lymphatic filariasis in a hunter-gatherer group in Madang Province. (2000) (6)
Analysis of patterns of growth inhibition of P. falciparum in synchronised cultures induced by serum from children and adults from Madang, Papua New Guinea. (1985) (6)
Genetic variants of soluble malate dehydrogenase in new guinea populations (2004) (6)
In-vivo susceptibility of Plasmodium falciparum to cholorquine in pregnant and non-pregnant women and in-vitro response of P. falciparum to chloroquine and mefloquine in Madang Province, Papua New Guinea. (1988) (6)
PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH (2010) (5)
Lymphocyte subsets in Eastern Highlanders of Papua New Guinea. (1991) (5)
EPIDEMIOLOGY OF INFECTIOUS MONONUCLEOSIS IN WESTERN AUSTRALIA A RETROSPECTIVE HOSPITAL SURVEY, 1966–1972 (1974) (5)
Effect of dietary protein levels on urea utilization in Papua New Guinea highlanders. (1986) (5)
Isotype specific immunoglobulin responses to the house dust mite Dermatophagoides pteronyssinus and the purified allergen Der p 1 in asthmatic and control subjects from the Eastern Highlands of Papua New Guinea (1988) (5)
Impaired cell-mediated immunity in Papua New Guinean infants. (1991) (5)
Mitochondrial genome diversity among Papuan-speaking people of Papua New Guinea (2005) (5)
The correlation between microscopical examination and erythrocyte band 3 (AE1) gene deletion in South-east Asian ovalocytosis. (1998) (4)
Reduction inincidence andprevalence of Plasmodium falciparum inunder-5-year-old children bypermethrin impregnation ofmosquito nets* (1987) (4)
Emerging asthma in the Okapa district of the Eastern Highlands province of Papua New Guinea: the problem and its implications. (1983) (4)
Cell-mediated immune responses in man to Epstein-Barr (EB) virus infection. (1979) (4)
Serological evidence for transmission of multiple dengue virus serotypes in Papua New Guinea and West Papua prior to 1963 (2017) (4)
Blood status and serum free amino acids in Papua New Guinea highlanders. (1985) (4)
Naturally acquired cellular immune responses to the synthetic malarial peptide SPf66 in children in Papua New Guinea. (1997) (4)
Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination (2017) (4)
Assessment of malaria morbidity in vaccine efficacy trials (1995) (4)
Rotavirus diarrhoea in children in the highlands of Papua New Guinea. (1992) (4)
Metaphysical personhood and traditional South Fore mortuary rites (2015) (4)
Ribotyping of Salmonella enterica serovar Typhi isolates from Papua New Guinea over the period 1977 to 1996. (2005) (3)
Past and present research activities of the Papua New Guinea Institute of Medical Research. (1999) (3)
Safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine (PedvaxHIB) in Papua New Guinean children. (1998) (3)
The prevalence of antibodies to human T-lymphotropic virus type I in different population groups in Papua New Guinea (2005) (3)
Incubation period of human prion disease – Author's reply (2006) (3)
Serotypic variation of culture‐adapted isolates of P. falciparum (1984) (3)
Nutritional status of some papua new guinea highlanders as assessed by physical measurements and blood analysis (1988) (3)
HEALTH AND DISEASE IN THE ORD RIVER AREA (1972) (2)
Hospital twinning between Australia and Papua New Guinea. (2003) (2)
Thyroid function in a formerly goitrous community on Karkar Island, Papua New Guinea. (1992) (2)
Small-area variations in the epidemiology of malaria in Madang Province. 1986. (2005) (2)
The importance of social structure for patterns of human genetic diversity: Y-chromosome and mitochondrial genome variation in Papuan speaking people of mainland Papua New Guinea (2005) (2)
The relationship between splenomegaly and antibody to the circumsporozoite protein of Plasmodium falciparum in two groups of women with high and low enlarged spleen rates in Madang, Papua New Guinea. (1990) (2)
The epidemiology of malaria in Papua (2003) (2)
A microassay for detecting merozoite inhibition suitable for routine laboratory use. (1983) (2)
Recent data on the properties of the viruses of kuru and transmissible virus dementias. (1975) (2)
Effects of low protein intake on protein metabolism of Papua New Guinea highlanders studied with [15N]glycine. (1988) (1)
SPECIAL ARTICLE Past and present research activities of the Papua New Guinea Institute of Medical Research (1999) (1)
HTLV-I antibody studies in villagers in East Sepik Province, Papua New Guinea (2005) (1)
Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children. (2001) (1)
HEALTH AND DISEASE IN THE ORD RIVER AREA (1972) (1)
Reflections on pneumonia in the tropics (2014) (1)
Reminiscences and reflections on kuru, personal and scientific (2008) (1)
The buttressing coalition of the PNGIMR: an example of international collaborative research. (2003) (1)
Chlamydia trachomatis infection and distribution of serovars in the Eastern Highlands Province, Papua New Guinea. (2007) (1)
APLASTIC ANÆMIA, ACUTE MYELOID LEUKÆMIA, AND E.B. VIRUS (1974) (1)
Introduction (2008) (1)
Serological studies of influenza, measles and mumps in the Purari Pawaia (1983) (1)
Some general factors to be considered when implementing a program to control pneumonia. (2010) (1)
Application of a Polymerase Chain Reaction-ELISA to Detect Wuchereria bancrofti in Pools of Wild-Caught Anopheles punctualatus in a Filariasis Control Area in Papua New Guinea (2019) (0)
Sporozoite Rates and Densities in the Members of the Anopheles punctulatus Complex. (1986) (0)
New Guinea Populations (2006) (0)
Adolf Saweri: a tribute. (2014) (0)
Delivery of health care in Papua New Guinea. (1979) (0)
National Policy for an Integrated Health System and Local Implementation: The Case of Papua New Guinea and the Nasioi. (2010) (0)
Letter: Aplastic anemia, acute myeloid leukemia, and EB virus. (1974) (0)
Histological and immunohistochemical features of cerebellar tissue in cases of kuru - A review of cases recovered from two distant sites (2017) (0)
Immune function in adult highland Papua New Guinea patients with pneumonia. (1989) (0)
Gajdusek, Blumberg, and Prions (2013) (0)
Neurological diseases in the pacific including recent aetiological observations (1971) (0)
The first 50 years of the Papua New Guinea Medical Journal: a celebration of its golden jubilee. (2005) (0)
HLA-DQA1 genotyping by polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) and restriction endonuclease digestion in Papua New Guinea. (1999) (0)
TROPICAL IMMUNOLOGY (1977) (0)
Selection of T cell epitopes on pre-erythrocytic Plasmodium falciparum antigens by artificial neural networks: validation of HLA class I binding peptides as T cell epitopes in an endemic area of Papua New Guinea. (1998) (0)
Lymphocyte studies in kuru patients. (1971) (0)
Entomologically assessed exposure to malaria sporozoites are confounded by bednet usage (1998) (0)
IGG SUBCLASS REACTIVITY TO A PROTECTIVE RECOMBINANT ANTIGEN CORRELATES WITH PARASITOLOGIC STATUS IN HUMAN FILARIASIS (1989) (0)
Characterisation of the host response to Plasmodium falciparum infection in acute non-complicated malaria. (1986) (0)
Symposium stream 2: The current status of malaria (1987) (0)
Leucocyte antigens of Aboriginal Australians. (1973) (0)
Antibacterial activity of murine spleen cell extract. (1978) (0)
The Medical Research Advisory Committee and health-related research in Papua New Guinea. (1984) (0)
BloodpressureinPapuaNewGuinea: asurveyoftwo highland villages intheAsaroValley (1985) (0)
Application of a Polymerase Chain Reaction-ELISA to Detect Wuchereria bancrofti in Pools of Wild-Caught Anopheles punctualatus in a Filariasis Control Area in Papua New Guinea (2019) (0)
Metal Layers at High Altitudes and Near the Polar Summer Mesopause (2003) (0)
A memorial tribute to Helena Vrbova. (2008) (0)
Microbiologic studies of tropical skin ulcers in papua new guinea (1988) (0)

This paper list is powered by the following services:

Other Resources About Michael Alpers

en.wikipedia.org

What Schools Are Affiliated With Michael Alpers?

Michael Alpers is affiliated with the following schools: